The androgens testosterone (T) and dihydrotestosterone (DHT), besides playing an important role in prostate development and growth, are also responsible for the development and progression of benign prostate hyperplasia (BPH) and prostate cancer. Therefore, the actions of these hormones can be antagonized by preventing the irreversible conversion of T into DHT by inhibiting 5α-reductase (5α-R)....

Correspondence: Thomas H Tarter Division of Urology, Southern Illinois University School of Medicine, PO Box 19665, Springfield, IL 62794-9665, US. Tel +1 217 545 7390 Fax +1 217 545 7305 email [email protected] Abstract: Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary symptoms, with a prevalence of 50% by the sixth decade of life. Hyperplasia of stromal and epithelial ...

Abstract Paclitaxel (Taxol™), an alkaloid of diterpenoid family, is one the most widely used anti-cancer drugs due to its effectiveness against a variety tumors. Rather than directly extraction and chemical synthesis paclitaxel or intermediates from yew plants, construction microbial cell factory for biosynthesis will be more efficient sustainable. The challenge lies on insufficient precursor, ...

The use of 5α-reductase inhibitors (5α-RIs) as prostate cancer chemoprevention agents is controversial. Two large randomized trials, the Prostate Cancer Prevention Trial (PCPT) and the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) Trial, have both shown a decreased incidence of prostate cancer in patients administered with 5α-RIs. Both studies showed, however, an increased risk of...

With aging, abnormal benign growth of the prostate results in benign prostate hyperplasia (BPH) with concomitant lower urinary tract symptoms (LUTS). Because the prostate is an androgen target tissue, and transforms testosterone into 5α-dihydrotestosterone (5α-DHT), a potent androgen, via 5α-reductase (5α-R) activity, inhibiting this key metabolic reaction was identified as a target for drug de...

This article summarizes the importance of different targets such as 5α-reductase, 17β-HSD, CYP17A, androgen receptor and protein kinase A for the treatment of prostate cancer and benign prostatic hyperplasia. It is a well known fact that dihydrotestosterone (DHT) is associated with the development of androgen-dependent afflictions. At the present time, several research groups are attempting to ...

Trends in skin and hair treatments focus on natural products due to undesired effects of chemically synthetic ingredients. This study aims investigate the cosmeceutical Equisetum debile (horsetail) extracts relating anti-hyperpigmentation via tyrosinase, anti-wrinkle formation matrix metalloproteinases (MMPs), anti-androgenic alopecia 5α-reductase. Ethanolic were sequentially partitioned into s...

ABSTRACT: Androgenetic alopecia is the chief type of scalp hair loss regardless of gender, causing anxiety, depression, arterial stiffness, and cardiovascular disease. The areal parts of Olea europaea (OE) and Trigonella foenum-graecum (TF), as well as the bulbs of Allium sativum (AS) are vastly used in Persian folklore for a great range of culinary and medicinal purposes. This study was an att...

BACKGROUND Androgenic alopecia (AGA) is a major type of human scalp hair loss, which is caused by two androgens: testosterone (T) and 5α-dihydrotestosterone (5α-DHT). Both androgens bind to the androgen receptor (AR) and induce androgen-sensitive genes within the human hair dermal papilla cells (HHDPCs), but 5α-DHT exhibits much higher binding affinity and potency than T does in inducing the in...

The development, growth, and function of the prostate gland depend on androgen stimulation. The primary androgen in prostate is 5α-dihydrotestosterone (DHT) which is synthesized from circulating testosterone (T) through the action of 5α-reductase (5α-R). Although 5α-R occurs as five isozymes, only 5α-R1 and 5α-R2 are physiologically involved in steroidogenesis. The endocrine disruptor bisphenol...